Citation, interpretation and commencement

1.—(1) This Order, which may be cited as the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1987, amends the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984(1) (hereinafter referred to as “the principal Order”) and shall come into force on 1st June 1987.

(2) In this Order, unless the context otherwise requires, a reference to inserting an entry in a column in a Table of a Schedule to the principal Order shall be construed, in the case of an entry to be inserted in column 1, as a reference to inserting that entry at the appropriate point in the alphabetical order of the entries in column 1 of that Table and, in the case of an entry to be inserted, as the case may be, in column 2 or 3, as a reference to inserting that entry so as to appear against the column 1 entry against which it is listed in this Order.

Amendment of Schedule 1 to the principal Order

2.—(1) Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of the principal Order), is amended in accordance with the following paragraphs of this article.

(2) In Table A (internal or external use)—

(a)there are inserted in column 1 and, as the case may be, columns 2 and 3, those entries set out in columns 1, 2 and 3 respectively of Schedule 1 to this Order, and

(b)for the entries in columns 1, 2 and 3 relating to the substances “Aloxiprin” and “Aspirin” there are respectively substituted the entries set out in Schedule 2 to this Order.

(3) In Table B (external use only)—

(a)there are inserted in column 1 and, as the case may be, column 2, those entries set out in columns 1 and 2 respectively of Schedule 3 to this Order, and

(b)there are deleted from column 1 the entries “Dichloroxylenol” and “Sassafras Oil” and from column 2 the entries relating to those substances.

Amendment of Schedule 2 to the principal Order

3.—(1) Schedule 2 to the principal Order (which specifies the class of medicinal products, the subject of a product licence of right, on general sale by virtue of article 2(b) of the principal Order), is amended in accordance with the following paragraphs of this article.

(2) In Table A (internal or external use)—

(a)for the entries in columns 1, 2 and 3 relating to the substances “Aloxiprin” and “Aspirin” there are respectively substituted the entries set out in Schedule 4 to this Order, and

(b)there are deleted from column 1 the entries “Birthwort”, “Inositol Nicotinate”, “Sassafras” and “Serpentary”.

(3) In Table B (external use only) there are deleted from column 1 the entries “Safrole” and “Sassafras Oil”.

Amendment of Schedule 3 to the principal Order

4.  In Schedule 3 to the principal Order (which specifies classes of medicinal products which are not on the general sale list), the word “or” is deleted from paragraph (e) and is inserted at the end of paragraph (f) and after paragraph (f) there is inserted, “(g) for administration wholly or mainly to children being a preparation of Aloxiprin or Aspirin”.